In vitro pharmacodynamics of nemonoxacin and other antimicrobial agents against Mycoplasma pneumoniae
ABSTRACT Mycoplasma pneumoniae is the causative agent of respiratory infections in children and adults. Macrolide still plays a significant role in treating infections by M. pneumoniae. However, macrolide-resistant M. pneumoniae (MRMP) was encountered, causing more severe or prolonged disease worldw...
Main Authors: | Na Wang, Yuancheng Chen, Xingyi Qu, Xingchen Bian, Jiali Hu, Xiaogang Xu, Li Xiao, Yang Liu, Jing Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Microbiology
2023-12-01
|
Series: | Microbiology Spectrum |
Subjects: | |
Online Access: | https://journals.asm.org/doi/10.1128/spectrum.02431-23 |
Similar Items
-
Pharmacokinetics and Pharmacodynamics of Nemonoxacin in a Neutropenic Murine Lung Infection Model Against Streptococcus Pneumoniae
by: Xin Li, et al.
Published: (2021-05-01) -
Integrative population pharmacokinetic/pharmacodynamic analysis of nemonoxacin capsule in Chinese patients with community-acquired pneumonia
by: Yuancheng Chen, et al.
Published: (2023-02-01) -
In vitro Activities of Nemonoxacin and Other Antimicrobial Agents Against Human Mycoplasma and Ureaplasmas Isolates and Their Defined Resistance Mechanisms
by: Na Wang, et al.
Published: (2019-08-01) -
Safety of oral nemonoxacin: A systematic review of clinical trials and postmarketing surveillance
by: Jinyi Yuan, et al.
Published: (2022-12-01) -
The efficacy and safety of nemonoxacin compared with levofloxacin in the treatment of community-acquired pneumonia: a systemic review and meta-analysis of randomized controlled trials
by: Chang SP, et al.
Published: (2019-02-01)